Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 2
2008 2
2009 3
2010 2
2012 3
2013 3
2014 3
2015 2
2016 2
2020 1
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Optimal therapeutic approaches to femoropopliteal artery intervention.
Das T. Das T. Catheter Cardiovasc Interv. 2004 Sep;63(1):21-30. doi: 10.1002/ccd.20063. Catheter Cardiovasc Interv. 2004. PMID: 15343563 Review.
Optimal therapy requires understanding the available options including exercise programs, pharmacologic medical therapy, surgery and interventional endovascular therapy. Rapidly advancing endovascular technology for enabling safe intervention in complex, long occlus …
Optimal therapy requires understanding the available options including exercise programs, pharmacologic medical therapy, surgery and inte …
Value-Based Interventions for Lower Extremity Peripheral Vascular Interventions.
Altin SE, Box LC, Das T, Feldman DN, Jayasuriya S, Klein AJ, Latif F, Li J, Parikh SA, Secemsky EA, Swaminathan RV; SCAI 2022 Think Tank Peripheral Consortium; Boutin E, Canorea-Vega F, Chakrabarti AK, Hasegawa J, Howie N, Kohler T, Lauridsen HM, Perez O, Rangwala N, Schicchi M, Taber M, Venditto J, Wimberger J, Zinn L. Altin SE, et al. Among authors: das t. J Soc Cardiovasc Angiogr Interv. 2023 Jan 4;2(1):100533. doi: 10.1016/j.jscai.2022.100533. eCollection 2023 Jan-Feb. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39132519 Free PMC article. No abstract available.
Safety and Efficacy of Radial Artery Access for Peripheral Vascular Intervention: A Single-Center Experience.
Sayfo S, Salih M, Moubarak G, Ibrahim R, Apala D, Das T, Banerjee S, Potluri S. Sayfo S, et al. Among authors: das t. Am J Cardiol. 2024 Sep 1;226:59-64. doi: 10.1016/j.amjcard.2024.06.025. Epub 2024 Jun 28. Am J Cardiol. 2024. PMID: 38945347
Of 491 PVI, 156 (31.8%) were performed through the RA. Anatomical locations for intervention were the femoral (44.8%), iliac (31.1%), popliteal (9.6%) peroneal (2.7%), tibial (9.9%), and subclavian (1.9%) arteries. ...Periprocedural complication rate was 3.84%, of which ac …
Of 491 PVI, 156 (31.8%) were performed through the RA. Anatomical locations for intervention were the femoral (44.8%), iliac (31.1%), …
The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
Weber MA, Kirtane AJ, Weir MR, Radhakrishnan J, Das T, Berk M, Mendelsohn F, Bouchard A, Larrain G, Haase M, Diaz-Cartelle J, Leon MB. Weber MA, et al. Among authors: das t. JACC Cardiovasc Interv. 2020 Feb 24;13(4):461-470. doi: 10.1016/j.jcin.2019.10.061. JACC Cardiovasc Interv. 2020. PMID: 32081240 Free article. Clinical Trial.
BACKGROUND: A blood pressure-reducing effect of renal denervation has been difficult to isolate in clinical investigations. METHODS: REDUCE HTN: REINFORCE (Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension) was a randomized, sham …
BACKGROUND: A blood pressure-reducing effect of renal denervation has been difficult to isolate in clinical investigations. METHODS: …
Recanalization of infrainguinal chronic total occlusions with the crosser system: results of the PATRIOT trial.
Laird J, Joye J, Sachdev N, Huang P, Caputo R, Mohiuddin I, Runyon J, Das T. Laird J, et al. Among authors: das t. J Invasive Cardiol. 2014 Oct;26(10):497-504. J Invasive Cardiol. 2014. PMID: 25274859 Free article. Clinical Trial.
PURPOSE: To evaluate the angiographic and functional outcomes of the Crosser chronic total occlusion (CTO) recanalization system used to facilitate crossing of infrainguinal occlusions resistant to conventional guidewire techniques. METHODS: Eighty-five patients with a pre …
PURPOSE: To evaluate the angiographic and functional outcomes of the Crosser chronic total occlusion (CTO) recanalization system used to fac …
Infrainguinal lesion-specific device choices: round-table discussion.
Das TS, Beregi JP, Garcia LA, Abul-Khoudoud O, Laird JR, Lumsden AB, Lyden SP, Mewissen MW, Shimshak TM. Das TS, et al. J Endovasc Ther. 2006 Feb;13 Suppl 2:II60-71. doi: 10.1177/15266028060130S210. J Endovasc Ther. 2006. PMID: 16472011 No abstract available.
Clinical Outcomes of Non-Stent-Based Interventions for Symptomatic Below-the-Knee Peripheral Artery Disease in the Excellence in Peripheral Artery Disease (XLPAD) Registry.
Sayfo S, Rosol ZP, Vazquez DF, Mamawala M, Bruneman BM, Weideman SG, Adelman KS, Jeong M, Ramanan B, Tsai S, Shammas NW, Monteleone PP, Nanjundappa A, Chu HB, Smith BL, Grimsley BR, Hohmann SE, Vasquez J Jr, Metzger C, Das TS, Gable DR, Eidt JF, Banerjee S. Sayfo S, et al. Among authors: das ts. Am J Cardiol. 2024 Oct 1;228:38-47. doi: 10.1016/j.amjcard.2024.07.016. Epub 2024 Aug 5. Am J Cardiol. 2024. PMID: 39111561
Nonstent treatment for BTK PAD with concomitant FP intervention leads to high procedural success and similar rates of 1-year MALE compared with isolated BTK intervention. Condensed Abstract: The vast majority of below-the-knee (BTK) peripheral artery disease (PAD) …
Nonstent treatment for BTK PAD with concomitant FP intervention leads to high procedural success and similar rates of 1-year MALE com …
Solid state, pulsed-wave 355 nm UV laser atherectomy debulking in the treatment of infrainguinal peripheral arterial disease: The Pathfinder Registry.
Das TS, Shammas NW, Yoho JA, Martinez-Clark P, Ramaiah V, Leon LR, Pacanowski JP, Tai Z, Ali V, Arslan B, Rundback J. Das TS, et al. Catheter Cardiovasc Interv. 2024 May;103(6):949-962. doi: 10.1002/ccd.31023. Epub 2024 Apr 2. Catheter Cardiovasc Interv. 2024. PMID: 38566525
AIMS: The Pathfinder multicenter registry was initiated to evaluate the safety and efficacy of the 355 nm laser atherectomy system in a real-world setting for the treatment of de novo, re-stenotic and in-stent restenosis (ISR) lesions in infrainguinal arteries of patients with pe …
AIMS: The Pathfinder multicenter registry was initiated to evaluate the safety and efficacy of the 355 nm laser atherectomy system in a real …
27 results